ePrints

Mast Cells Are a Source of Transforming Growth Factor β in Systemic Sclerosis

Lookup NU author(s): Dr Thomas Huegle, Dr Vanessa Hogan, Dr Kathryn White, Professor Jaap Van Laar

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Objective. To describe the cellular source of transforming growth factor beta (TGF beta) in the dermis of patients with systemic sclerosis (SSc). Methods. We performed electron microscopy (EM) with immunogold labeling on skin biopsy specimens from 7 patients with SSc and 3 healthy control subjects. For TGF beta quantification, the numbers of gold particles per square micron were calculated. The origin of mast cells was confirmed and quantified by toluidine blue staining and light microscopy. Degranulation was assessed on toluidine blue-stained sections and on EM images. Results. In all patients, active TGF beta was observed uniquely in mast cell vesicles, some of which were released into the extracellular space. Patients with progressive SSc and a more recent onset of non-Raynaud's phenomenon symptoms had higher numbers of mast cells and gold particles per mast cell. Mast cells from healthy control subjects also contained active TGF beta but, in contrast to SSc samples, showed a resting character with no or low-level degranulation and uniformly dense osmiophilic vesicles. Conclusion. Degranulation of skin mast cells can be an important mechanism of TGF beta secretion in SSc.

Publication metadata

Author(s): Hugle T, Hogan V, White KE, van Laar JM

Publication type: Article

Publication status: Published

Journal: Arthritis & Rheumatism

Year: 2011

Volume: 63

Issue: 3

Pages: 795-799

Print publication date: 25/02/2011

ISSN (print): 0004-3591

ISSN (electronic): 1529-0131

Publisher: John Wiley & Sons, Inc.

URL: http://dx.doi.org/10.1002/art.30190

DOI: 10.1002/art.30190

Altmetrics

Share